Jump In July 2026
Face your fears and support Retina UK with a charity skydive this summer!
Search
Search results
Halloween Skydive 2026
Are you ready to sign up for a spooky skydive and face your fears for Retina UK?
Gaming & Streaming
Do you love gaming? Why not take on a gameathon, stream as you play and ask your audience to sponsor you?
‘Talking’ Tech Peer Support Group
Wednesday 6 May 2026, 7.00pm - 8.00pm - via Zoom - Please come and join Anna & Ellie for our latest meeting where we are delighted to welcome our guest speakers David Sikharulidze, founder & CEO and Martin Wingfield, CMO from Mavis Technologies.
‘Talking’ Books Peer Support Group
Wednesday 29 April 2026, 7.00pm - 8.00pm - via Zoom - Please come and join facilitators Cindy & Jane for our second meeting with our guest speaker John Darker who will be sharing his love of audiobooks and knowledge around listening to them via Audible.
SB-007 update: dose-expansion portion of SpliceBio’s phase 1/2 trial underway with first participant dosed at Oxford
SpliceBio has begun the dose-expansion portion of their phase 1/2 clinical trial of SB-007, a dual adeno-associated viral vector gene therapy for Stargardt disease.
Belite Bio – Phase 2/3 Trial for Adolescents with Stargardt disease
The latest research news piece from Retina UK.
SB-007, we’ve been expecting you
Introducing Splice Bio, a genetic medicines company with some exciting developments for Stargardt’s patients.
Antabuse moves into clinical trial for people with RP
Disulfiram (Antabuse), FDA-approved for deterring alcohol, is in a phase 1 trial at the University of Washington to improve vision in retinitis pigmentosa.
Easter Fundraising
If you could use the long bank holiday weekend to fundraise for Retina UK, we would love to hear from you!